Inscription Capital, LLC Astrazeneca PLC Transaction History
Inscription Capital, LLC
- $661 Million
- Q3 2024
A detailed history of Inscription Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Inscription Capital, LLC holds 12,015 shares of AZN stock, worth $784,459. This represents 0.14% of its overall portfolio holdings.
Number of Shares
12,015
Previous 12,339
2.63%
Holding current value
$784,459
Previous $962,000
2.7%
% of portfolio
0.14%
Previous 0.16%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,357Shares Held
493MCall Options Held
5.1MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.24 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.74 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.65 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.4 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.26 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $202B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...